CompletedNot Applicable

Pathogenesis and Mechanisms of Mitral Annular Calcification

United States45 participantsStarted 2020-07-28

Plain-language summary

Researchers are testing blood or mitral valve tissue to better understand the reasons why Mitral Annular Calcification (MAC) develops in patients with heart disease.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with diagnosis of MAC and patients coming to the Valve Clinic without MAC diagnosis Patients who will undergo surgery, either standard surgical MVR or trans-atrial TMVR, with diagnosis of MAC or without diagnosis of MAC Exclusion Criteria: * Subjects unwilling to participate or to provide consent

What they're measuring

Prognostic markers of calcific cardiac valves

Timeframe: Baseline

Trial details

NCT IDNCT04286009

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-01

View on ClinicalTrials.gov More Mitral Annulus Calcification trials